Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ardana Bioscience Ltd.

This article was originally published in Start Up

Executive Summary

A recent spin-off from the UK's government-funded Medical Research Council, Ardana Bioscience Ltd. has been set up to commercialize research into women's health. On its agenda are new products for underserved areas such as menstrual disorders and endometriosis; more convenient contraceptive drugs--including the male pill--and a product to ease childbirth. Rather than commercializing a specific patented technology, like most spin-offs, the company has the option to acquire rights to any technology generated by the MRC's Human Reproductive Sciences Unit in Edinburgh over the next five years.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts